glp 1 schizophrenia New Weight Loss Drugs in Psychiatry Exploring glucagon-like peptide-1 receptor agonists

The Kaiser Permanente Medical Weight Management Program is open to Kaiser members and non-members

NAION is a time-sensitive diagnosis, and early assessment matters, even if treatment options are limited

Multiple autoimmune conditions responding simultaneously to a single intervention is unusual in rheumatology, where treatment typically requires different medications targeting different pathways

Improper storage of Ozempic, such as exposure to freezing temperatures or excessive heat, primarily risks reducing the medications effectiveness

177,178,179 The ongoing ZEUS trial (NCT05021835) aims to evaluate the potential of zymokimab to reduce MACEs in patients with ASCVD, chronic kidney disease, and inflammation